Analystreport

Gossamer Bio, Inc. (NASDAQ: GOSS) had its price target lowered by analysts at Barclays PLC from $2.00 to $1.50.

Gossamer Bio, Inc.  (GOSS) 
Last gossamer bio, inc. earnings: 3/24 07:00 am Check Earnings Report